Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study II
Clinical trial NCT02677805 · COMPLETED
Trial details
- NCT number
- NCT02677805
- Sponsor
- Croma-Pharma GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-30
- Primary completion
- 2016-09-15
- Enrollment
- 251
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.